Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Kedem Pharmaceuticals Inc.
DescriptionSublingual formulation of calcitonin gene-related peptide (CGRP) receptor antagonist
Molecular Target Calcitonin gene-related peptide (CGRP) receptor
Mechanism of ActionCalcitonin gene-related peptide (CGRP) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMigraine
Indication DetailsPrevent migraine
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today